Clinical trial
Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer
NCT04850937 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer
- Lead sponsor
- Yangzhou University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 10, 2021
- Completion date
- May 10, 2022
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression